JETO HomeIssue Contents

Human tumor cell sensitivity to oleandrin is dependent on relative expression of Na+, K+-ATPase subunits
Yun Lin, Dah H. Ho, Robert A. Newman

The membrane enzyme Na<+, K+-ATPase is known to help maintain ion homeostasis in mammalian cells. Newly identified functions of this enzyme suggest that inhibition of Na+, K+-ATPase by cardiac glycosides may be useful to patients with cancer. Twelve human tumor cell lines were chosen to examine determinants of human tumor cell sensitivity to cardiac glycosides. In vitro cell culture models of human glioma HF U251 and U251 cells as well as human parental and modified melanoma BRO cells were also included in these studies. Data derived from both models and twelve tumor cell lines indicated that high expression of Na+, K+-ATPase alpha 1 isoform in the presence of low alpha 3 expression correlated with increased resistance to inhibition of cell proliferation by cardiac glycosides such as oleandrin, ouabain and bufalin. Interestingly, increased expression of Na+, K+-ATPase alpha 1 and therefore total Na+, K+-ATPase activity is associated with increased cellular levels of glutathione. The altered enzyme activity and glutathione content were associated with a delayed and diminished release of cytochrome c and caspase activation. Additionally, an increased colony-forming ability was noted in cells with high levels of Na+, K+-ATPase alpha 1 expression, suggesting that Na+, K+-ATPase alpha 1 isoform may be actively involved in tumor growth and cell survival. Its inhibition by cardiac glycosides may provide a strategy for effective cancer therapy.

Keywords: Cardiac glycosides, Na+, K+-ATPase, alpha 1 isoform, cell growth, and glutathione

Full Text (IP)